Sonia Accossato, Senior Scientist and Business DevelopmentServing a wide range of research areas—including metabolism, inflammation, infectious diseases, hemostasis, tumor diseases and veterinary science—BMA Biomedicals’ offerings are designed to cater to the complex demands of the scientific community. This versatility makes them a trusted resource for researchers across multiple fields of study.
Among its offerings, BMA’s calprotectin ELISA assay empowers researchers to precisely measure this key inflammatory marker in biological fluids, aiding in diagnosing and monitoring inflammatory diseases like Crohn's.
To quantify semaglutide, a peptide of significant interest in diabetes and weight loss research, BMA developed an ELISA kit that has garnered positive feedback from satisfied customers.
“For over 35 years, we have refined our approach by actively engaging with researchers and fostering collaborative partnerships beyond the traditional supplier-client relationship,” says Sonia Accossato, senior scientist and business development.
BMA is also dedicated to ethical and sustainable practices, as demonstrated by its use of fetal calf serum-free culture media in monoclonal antibody production. This method prioritizes animal welfare, enhances experimental reproducibility and reduces contamination risks, resulting in more consistent and reliable outcomes for researchers.
Cutting-edge technologies, including hybridoma and single B cell techniques, are used to produce high-quality, consistent monoclonal antibodies. BMA is now exploring the potential of AI in antibody design to enhance precision, speed and cost-effectiveness, providing researchers with advanced tools more rapidly and at potentially lower costs.
Open communication with clients is central to BMA’s approach. It shares data and addresses inquiries to foster strong partnerships and build trust. This collaborative approach ensures researchers receive the support needed to maximize the potential of BMA’s products, empowering them to achieve their research goals and drive groundbreaking discoveries.
“Witnessing our products contribute to scientific breakthroughs published worldwide fills us with immense pride. The positive feedback from satisfied customers fuels our passion for empowering researchers and making a tangible impact in the scientific community,” adds Accossato.
BMA’s global distributor network reinforces its commitment to researchers worldwide. It ensures easy access to high-quality products and stays attuned to the evolving needs of the scientific community. Whether meeting tight deadlines or providing ongoing support, BMA consistently demonstrates its dedication to customer satisfaction.
This is evident in a large client order with an exceptionally tight deadline. The team reprioritized tasks and collaborated seamlessly to ensure timely delivery, enabling the client to continue their critical work without disruption and highlighting BMA’s customer-centric philosophy and willingness to go the extra mile to support client success.
Witnessing our products contribute to scientific breakthroughs published worldwide fills us with immense pride. The positive feedback from satisfied customers fuels our passion for empowering researchers and making a tangible impact in the scientific community.
Active participation in seminars keeps the company informed about emerging research trends, while customer feedback informs the development of new products. This proactive approach ensures researchers always have access to the most relevant and innovative investigative tools.
BMA embodies the fusion of Swiss precision with a customer-centric ethos. Its promise of quality, innovation and collaboration has solidified its position as a leader in the biomedical industry, empowering countless researchers in their quest for scientific breakthroughs. As it pushes the boundaries of possibility through cutting-edge technologies and steadfast support, BMA stands as a beacon of excellence, illuminating the path toward a brighter, healthier future.
